**Core Concept**
Atracurium is a non-depolarizing neuromuscular blocker that undergoes Hoffman elimination, a chemical process that occurs in the plasma and tissue buffer systems. This process can lead to the accumulation of metabolites, including laudanosine, which has central nervous system stimulatory effects.

**Why the Correct Answer is Right**
The accumulation of laudanosine is a well-known side effect of prolonged atracurium infusion. Laudanosine is a metabolite of atracurium that is produced through Hoffman elimination, and it can cross the blood-brain barrier, leading to seizures, tremors, and other central nervous system effects. The risk of laudanosine accumulation increases with prolonged infusion times, making **Option A** the most probable cause of seizures in this patient.

**Why Each Wrong Option is Incorrect**
**Option B:** Allergy to the drug is unlikely to cause seizures as a primary symptom. While anaphylaxis or other allergic reactions to atracurium can occur, they typically present with symptoms such as rash, hypotension, and bronchospasm, rather than seizures.

**Option C:** Prolonged infusion of atracurium can lead to accumulation of laudanosine, but it is not the cause of seizures in this scenario. The duration of infusion is a contributing factor, but it is not the primary reason for the seizures.

**Clinical Pearl / High-Yield Fact**
It is essential to monitor patients receiving atracurium for signs of laudanosine accumulation, such as seizures, tremors, and altered mental status. The risk of laudanosine accumulation can be minimized by using alternative neuromuscular blockers or adjusting the infusion rate and duration.

**Correct Answer:**
✓ Correct Answer: A. Accumulation of laudanosine